Evidence Synthesis
CRANEINFRA 1663 shares, 12.57 INR, and 100%, up from 47.59%.
The company's revenue growth yoy accelerated to 0%, up from . Its marginal operating leverage accelerated to , up from 32.55%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 22 Jul 2026, 13:55
Evidence Synthesis
CRANEINFRA 1663 shares, 12.57 INR, and 100%, up from 47.59%.
The company's revenue growth yoy accelerated to 0%, up from . Its marginal operating leverage accelerated to , up from 32.55%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 100 % | 47.59 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 47.59 % | 32.55 | ▲ |
| REVENUE_GROWTH_YOY | 0 % | -46.9 | ▲ |
| PRICE_CHANGE_PERCENT | 0.56 % | — | - |
| DAILY_VOLUME | 1,663 shares | 2,017 | ▼ |
| CLOSE_PRICE | 12.57 INR | 12.5 | ▲ |